NASDAQ:NYMX Nymox Pharmaceutical (NYMX) News Today Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.19▼$0.4752-Week Range N/AVolume932,700 shsAverage Volume94,622 shsMarket Capitalization$18.10 millionP/E RatioN/ADividend YieldN/APrice TargetN/A HeadlinesProfileEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNymox Pharmaceutical Corporation (NYMXF)finance.yahoo.com - September 26 at 11:43 PMNymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPHmarkets.businessinsider.com - September 25 at 12:31 PMNymox Reports Completion of $2 Million Private Placementmarkets.businessinsider.com - August 29 at 3:42 PMNymox Pharmaceutical Corporation: Nymox Reports on U.S. Patent Issuancesfinanznachrichten.de - July 18 at 3:50 PMNymox Reports on U.S. Patent Issuancesfinance.yahoo.com - July 18 at 3:50 PMThe Committee to Restore Nymox Shareholder Value Soundly Rebuts Injurious Allegations Made by Nymox Pharmaceutical Corp Current Managementventurebeat.com - July 16 at 8:00 PMNymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of Nymoxfinance.yahoo.com - July 12 at 12:12 PMRebuttal Letters Issued to Shareholders of NYMOX PHARMACEUTICAL CORP (“NYMX-Q”)venturebeat.com - July 9 at 3:33 PMNymox Pharmaceutical Corporation: NYMOX Updatefinanznachrichten.de - July 8 at 1:16 PMNYMOX Updatefinancialpost.com - July 7 at 6:03 PMWhy Is Nymox Pharmaceutical (NYMX) Stock Down 18% Today?investorplace.com - July 6 at 11:02 AMNymox Pharmaceutical receives potential delisting notice from Nasdaqseekingalpha.com - July 6 at 8:36 AMNYMX Tanks after Receiving Delisting Noticemsn.com - July 6 at 8:36 AMNymox Delisting from NASDAQfinancialpost.com - July 5 at 6:15 PMNYMX - Nymox Pharmaceutical Corporationfinance.yahoo.com - June 30 at 1:14 PMNymox Pharmaceutical (NYMX) Stock Down After Disappointing Enlarged Prostate Treatment Test Resultsthestreet.com - June 28 at 12:29 AMNymox Pharmaceutical (NASDAQ: NYMX)fool.com - June 15 at 7:42 AMNymox Pharmaceutical Corporation: Nymox Provides Current Updatefinanznachrichten.de - May 10 at 2:18 PMNymox Provides Corporate Updatefinance.yahoo.com - April 3 at 12:47 PMNymox Announces Appointment of Christopher R. Riley as Chief Financial Officerfinance.yahoo.com - March 21 at 3:52 PMNymox Officially Granted Extension to Regain Listing Requirementsfinance.yahoo.com - March 15 at 12:41 PMOne Nymox Pharmaceutical Corporation (NASDAQ:NYMX) insider upped their stake by 32% in the previous yearfinance.yahoo.com - March 6 at 7:03 AMNymox Announces NYMOZARFEX Marketing Application is Accepted For Reviewfinance.yahoo.com - February 15 at 1:47 PMNYMOX Appeals Deficiency Letterfinance.yahoo.com - January 6 at 5:32 PMNYMOX Announces New Marketing Submission for NYMOZARFEX™ for BPHfinance.yahoo.com - December 5 at 1:15 PMMay 2023 Market Cap Requirement Updatefinancialpost.com - November 25 at 3:59 PMA Nymox Pharmaceutical Corporation (NASDAQ:NYMX) insider increased their holdings by 32% last yearfinance.yahoo.com - September 27 at 8:24 AMWe Think Nymox Pharmaceutical (NASDAQ:NYMX) Needs To Drive Business Growth Carefullynasdaq.com - August 17 at 8:36 AMU.S. shares higher at close of trade; Dow Jones Industrial Average up 2.15%msn.com - July 15 at 5:40 PMNYMOX Updates Shareholdersfinance.yahoo.com - July 15 at 12:39 PMNYMOX Receives Deficiency Letter from NASDAQfinance.yahoo.com - July 14 at 4:15 PMNymox Pharmaceutical Down 64% on FDA Refusal to File Lettermarketwatch.com - May 23 at 11:44 PMNYMOX Receives RTF letter from FDAstockhouse.com - May 23 at 6:43 PMNYMOX down 46% on Refuse to File letter from FDA for fexapotide for enlarged prostateseekingalpha.com - May 23 at 6:43 PMNymox Application for Fexapotide Triflutate Rejected by FDA >NYMXmarketwatch.com - May 23 at 6:43 PMWhy Nymox Pharma Shares Sinking to 52-Week Low?benzinga.com - May 23 at 10:19 AMmarketbeat.com - May 23 at 8:25 AMExecutives Buy Around $5M Of 4 Penny Stocksuk.investing.com - May 9 at 1:45 PMFriday 5/6 Insider Buying Report: ALGN, NYMXnasdaq.com - May 6 at 12:42 PMNymox Announces Closing of $6.4 Million Financingfinance.yahoo.com - April 4 at 7:11 PMA Nymox Pharmaceutical Corporation (NASDAQ:NYMX) insider increased their holdings by 1.1% last yearfinance.yahoo.com - April 3 at 5:41 PMNymox: Q4 Earnings Snapshotsfgate.com - March 31 at 6:54 PMHere's Why Nymox Pharmaceuticals Shares Are Movingmsn.com - March 18 at 3:30 PMNymox Direct Offeringbaystreet.ca - March 18 at 10:29 AMNymox Pharmaceutical announces $5M registered direct offeringseekingalpha.com - March 18 at 10:29 AMNymox Announces $5 Million Registered Direct Offeringfinance.yahoo.com - March 18 at 10:29 AMNymox Seeks FDA OK for Enlarged Prostate Treatment >NYMXmarketwatch.com - March 3 at 5:06 PMNymox stock rises 8% as it files for FDA approval of drug treating enlarged prostateseekingalpha.com - March 3 at 5:06 PMNYMOX Announces Submission of New Drug Application (NDA) to the FDA for Fexapotide Triflutatefinance.yahoo.com - March 3 at 5:06 PMInsiders at Nymox Pharmaceutical Corporation (NASDAQ:NYMX) recouped some losses this week after buying this year, still down US$31knasdaq.com - January 3 at 2:38 PM Get Nymox Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for NYMX and its competitors with MarketBeat's FREE daily newsletter. Email Address NYMX Media Mentions By Week NYMX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NYMX News Sentiment▼0.000.70▲Average Medical News Sentiment NYMX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NYMX Articles This Week▼10▲NYMX Articles Average Week Get Nymox Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for NYMX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Biomerica News MyMD Pharmaceuticals News OncoCyte News Navidea Biopharmaceuticals News Trinity Biotech News Virax Biolabs Group News Cardio Diagnostics News ImmuCell News Aspira Women's Health News VolitionRx News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:NYMX) was last updated on 10/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nymox Pharmaceutical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.